J Neurol Neurosurg Psychiatry 81:1413-1414 doi:10.1136/jnnp.2009.195776
  • PostScript
  • letter

Multiple sclerosis and risk of cancer: a meta-analysis

  1. Sreeram V Ramagopalan1,2
  1. 1Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
  2. 2Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, UK
  1. Correspondence to Dr Sreeram V Ramagopalan, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK; sreeramr{at}
  • Received 21 September 2009
  • Revised 11 November 2009
  • Accepted 16 November 2009
  • Published Online First 19 August 2010

We read with interest the study by Fois and colleagues, showing no change in the risk of cancer in multiple sclerosis (MS) patients compared with the normal population.1 However, we note that a previous study published this year suggested that MS patients are at lower risk of cancer than the normal population.2 Resolving this controversy is of huge importance for patients and perhaps also for assessing potential adverse effects of immunomodulatory therapies for MS.3

These recent reports, utilising powerful population-based registries, have both shown a decreased risk for all cancers in MS patients, with statistical significance achieved in one study2 but not in …

Responses to this article

Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article